Kala Pharmaceuticals Inc. (KALA)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
RA Capital Management

Peter Kolchinsky

10,874,613 $81,560 1.49%
2.
OrbiMed Advisors

Samuel Isaly

5,465,030 $40,988 +2% 0.51%
3.
Vivo Capital

Albert Cha And Frank Kung

786,883 $5,902 0.34%
4.
Ikarian Capital

Neil Shahrestani

451,531 $3,387 0.24%
5.
Samsara BioCapital

Srini Akkaraju And Michael Dybbs

451,162 $3,384 +34% 0.94%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$7.60 40 Officer 42 2020-10-22 Filing
$13.39 2 Officer 2 2020-06-05 Filing
$5.75 10,000 Officer 10,000 2020-03-16 Filing
$7.89 2,534,854 Director 2,534,854 2020-03-13 Filing
$7.89 6,337,135 Large Shareholder, Director 10,874,613 2020-03-13 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 48,200 $361,500 0%
2. 10,155 $76,162 0%
3. 4,870 $36,523 0.01%
4. 3,472,370 $26,043 0%
5. 3,450,000 $25,875 0.5%
News See All